Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
Isocel (ALEXIS-ISO-1) - Kiromic
Tecartus (brexucabtagene autoleucel) - Gilead
Carvykti (ciltacabtagene autoleucel) - J&J
Yescarta (axicabtagene ciloleucel) - Gilead
Abecma (idecabtagene vicleucel) - BMS
https://acrabstracts.org/abstract/a-post-marketing-analysis-of-autoimmune-toxicities-following-chimeric-antigen-receptor-t-cell-therapy-using-the-fda-adverse-event-reporting-system/
 
Malvika Gupta1; Christopher Graham2; Supriya Gupta3
 
Sep 15, 2025
 
Next